| Catalog Number |
202050 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Post Operative Wound Infection (2446)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
An investigation has been initiated based on the reported information.Upon completion of the investigation, a follow-up report will be submitted.
|
| |
|
Event or Problem Description
|
|
This report is for patient # 2 and is related to mfg report numbers 3003418325-2025-00059 and 3003418325-2025-00061: a facility reported that they are looking into a string of infections in 3 patients and mentioned that all 3 patients also had duraseal used during their procedure.The infectious disease physician at the facility stated that he doesn't believe it had anything to do with the infections but is just testing everything that was used on each patient.Additional information has been requested.
|
| |
|
Additional Manufacturer Narrative
|
|
The duraseal dural sealant system 5ml us box of 5 (202050) was not was not received for testing; therefore, the failure mode could not be confirmed.Additionally, the dhr review was unable to be performed as no valid lot number was reported.As a result, the root cause is undetermined.Per the dfmea, potential causes of failure include: biocompatibility, and the risk remains acceptable per the risk analysis.No enhancements or improvements were generated for the reported condition.The complaint will be closed as could not be reliably determined.Should new information become available, the file will be reopened, and the investigation summary will be amended as appropriate.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
|
| |
|
Event or Problem Description
|
|
N/a.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated fields: g3, g6, h2, h3, h6 (type of investigation), h11 (update to previous mfg narrative).Duraseal dural sealant system 5ml us box of 5 (202050) was not received for testing; therefore, the failure mode could not be confirmed.Additionally, the dhr review was unable to be performed as no valid lot number was reported.As a result, the root cause is undetermined.Per the fmea, potential causes of failure include: biocompatibility.The risk remains acceptable per the risk analysis, and after review of historical complaint data, no trend has been identified for infection.Additionally, medical safety has also reviewed the complaints and confirmed there is no adverse trend.As a result, no enhancements or improvements were generated for the reported condition.The complaint will be closed as cannot be reliably determined.Should new information become available, the file will be reopened, and the investigation summary will be amended as appropriate.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
|
| |
|
Search Alerts/Recalls
|